[HTML][HTML] Trends in the care of diabetic macular edema: analysis of a national cohort
BL VanderBeek, N Shah, PC Parikh, L Ma - Plos one, 2016 - journals.plos.org
Purpose To evaluate how the monitoring and treatment for diabetic macular edema (DME)
has changed in a national sample. Design Retrospective cohort study. Methods Setting …
has changed in a national sample. Design Retrospective cohort study. Methods Setting …
Treatment patterns in diabetic macular edema in Taiwan: a retrospective chart review
SJ Sheu, CK Cheng, HK Kuo, CY Tsai… - Clinical …, 2018 - Taylor & Francis
Objectives To characterize diabetic macular edema (DME) treatment patterns in Taiwan and
examine their impact on health care resource utilization and visual and anatomic outcomes …
examine their impact on health care resource utilization and visual and anatomic outcomes …
The role of anti-VEGF therapy in the treatment of diabetic macular edema
DM Moshfeghi, PK Kaiser, S Michels… - … Surgery, Lasers and …, 2016 - journals.healio.com
Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults. DR
often leads to diabetic macular edema (DME), which often goes unnoticed until a patient …
often leads to diabetic macular edema (DME), which often goes unnoticed until a patient …
Management paradigms for diabetic macular edema
P Mitchell, TY Wong… - American journal of …, 2014 - Elsevier
Purpose To provide evidence-based recommendations for diabetic macular edema (DME)
management based on updated information from publications on DME treatment modalities …
management based on updated information from publications on DME treatment modalities …
[HTML][HTML] Vision outcomes following anti–vascular endothelial growth factor treatment of diabetic macular edema in clinical practice
NM Holekamp, J Campbell, A Almony… - American journal of …, 2018 - Elsevier
Purpose To determine monitoring and treatment patterns and vision outcomes in real-world
patients initiating anti–vascular endothelial growth factor (anti-VEGF) therapy for diabetic …
patients initiating anti–vascular endothelial growth factor (anti-VEGF) therapy for diabetic …
Diabetic macular edema diagnosis and treatment in the real world: an analysis of Medicare claims data (2008 to 2010)
PU Dugel, A Layton, R Varma - Ophthalmic Surgery, Lasers and …, 2016 - journals.healio.com
BACKGROUND AND OBJECTIVE: To characterize vascular endothelial growth factor
(VEGF) inhibitor treatment patterns in patients with diabetic macular edema (DME) using a …
(VEGF) inhibitor treatment patterns in patients with diabetic macular edema (DME) using a …
Current and emerging treatment for diabetic macular edema
C Ung, DS Borkar, LH Young - International ophthalmology clinics, 2017 - journals.lww.com
Diabetic macular edema (DME) is the most common cause of visual impairment in patients
with diabetes mellitus and affects B6. 8% of the diabetic population. 1 The Diabetes Control …
with diabetes mellitus and affects B6. 8% of the diabetic population. 1 The Diabetes Control …
Yearly treatment patterns for patients with recently diagnosed diabetic macular edema
TA Moulin, EA Boakye, LS Wirth, J Chen… - Ophthalmology …, 2019 - Elsevier
Purpose To describe the treatment patterns and the predictors of different treatment
standards in recently diagnosed diabetic macular edema (DME) patients in a nationally …
standards in recently diagnosed diabetic macular edema (DME) patients in a nationally …
Anti–vascular endothelial growth factor treatment for diabetic macular edema in a real-world clinical setting
E Maggio, M Sartore, M Attanasio, G Maraone… - American Journal of …, 2018 - Elsevier
Purpose To report the long-term outcomes of intravitreal anti–vascular endothelial growth
factor (VEGF) treatment for diabetic macular edema (DME) in a real-world clinical setting …
factor (VEGF) treatment for diabetic macular edema (DME) in a real-world clinical setting …
[HTML][HTML] Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study
J Wirkkala, AM Kubin, P Ohtonen, J Yliselä, T Siik… - BMC …, 2022 - Springer
Background The treatment for diabetic macular edema (DME) has revolutionized during the
last 15 years after the introduction of intravitreal anti-VEGF agents. The aim of the current …
last 15 years after the introduction of intravitreal anti-VEGF agents. The aim of the current …